|
Designation |
Company |
 CEO |
Publicly-listed Pharma |
|
CEO |
Private Biopharmaceutical |
|
Regional Head, Asia |
European Biopharmaceutical |
|
President |
Generics Pharma |
|
Business Head, Africa |
Multi-national Pharma |
|
COO, Canada |
US Subsidiary, Specialty Pharma |
|
VP, External Research |
European Pharma |
|
President, R&D |
Publicly-listed Generics Pharma |
|
Regional Head, Asia |
US Publicly-listed Chemicals |
|
VP, Commercial Operations |
US Subsidiary, Biopharma |
|
VP, Regulatory Affairs |
US Subsidiary, Generics Pharma |
|
VP, Business Development |
US Subsidiary, Specialty Pharma |
|
VP & GM |
US Specialty Chemicals |
|
SVP, Process Development |
Publicly-Listed Biopharma |
|
CEO |
Hospital Chain |
|
CEO, Japan |
Japanese Subsidiary, Generics Pharma |
|
Medical Director |
Rx Pharma |
|
General Manager, Quality |
Pharma, MENA |
|
|
Designation |
Company |
|
VP, Business Development, Japan |
Japanese Subsidiary, Generics Pharma |
|
Country Head, China |
US Rx Pharma |
|
Country Head, India |
US Rx Pharma |
|
Regional Head, Middle East |
US Rx Pharma |
|
CEO, Brazil |
Private Generics Pharma |
|
Regional Head, Latin America |
US Rx Pharma |
|
VP, Europe |
European Subsidiary, Generics Pharma |
|
President, Europe |
European Subsidiary, Specialty Pharma |
|
VP, Business Development CRAMS |
Multi-national CRO |
|
GM, Operations/ Manufacturing |
US Pharma |
|
VP, Strategic Planning |
US Publicly-listed Chemicals |
|
VP, Formulations |
Japanese Specialty Pharma |
|
SVP, Medicinal Chemistry |
Publicly-listed Pharma |
|
VP, API |
Private Pharma |
|
VP, Clinical Development |
Publicly-listed Pharma |
|
Director, Human Resource |
Pharma, MENA |
|
|
|
|
